The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung

Mycobacterium tuberculosis (Mtb) genes encoding proteins targeted by vaccines and drugs should be expressed in the lung, the main organ affected by Mtb, for these to be effective. However, the pulmonary expression of most Mtb genes and their proteins remains poorly characterized. The aim of this stu...

Full description

Bibliographic Details
Main Authors: Mariateresa Coppola, Rachel P-J. Lai, Robert J. Wilkinson, Tom H. M. Ottenhoff
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.763364/full
_version_ 1818968799482740736
author Mariateresa Coppola
Rachel P-J. Lai
Rachel P-J. Lai
Robert J. Wilkinson
Robert J. Wilkinson
Robert J. Wilkinson
Tom H. M. Ottenhoff
author_facet Mariateresa Coppola
Rachel P-J. Lai
Rachel P-J. Lai
Robert J. Wilkinson
Robert J. Wilkinson
Robert J. Wilkinson
Tom H. M. Ottenhoff
author_sort Mariateresa Coppola
collection DOAJ
description Mycobacterium tuberculosis (Mtb) genes encoding proteins targeted by vaccines and drugs should be expressed in the lung, the main organ affected by Mtb, for these to be effective. However, the pulmonary expression of most Mtb genes and their proteins remains poorly characterized. The aim of this study is to fill this knowledge gap. We analyzed large scale transcriptomic datasets from specimens of Mtb-infected humans, TB-hypersusceptible (C3H/FeJ) and TB-resistant (C57BL/6J) mice and compared data to in vitro cultured Mtb gene-expression profiles. Results revealed high concordance in the most abundantly in vivo expressed genes between pulmonary Mtb transcriptomes from different datasets and different species. As expected, this contrasted with a lower correlation found with the highest expressed Mtb genes from in vitro datasets. Among the most consistently and highly in vivo expressed genes, 35 have not yet been explored as targets for vaccination or treatment. More than half of these genes are involved in protein synthesis or metabolic pathways. This first lung-oriented multi-study analysis of the in vivo expressed Mtb-transcriptome provides essential data that considerably increase our understanding of pulmonary TB infection biology, and identifies novel molecules for target-based TB-vaccine and drug development.
first_indexed 2024-12-20T14:10:26Z
format Article
id doaj.art-76ba31ced65644ab960217e2702e2944
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-20T14:10:26Z
publishDate 2021-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-76ba31ced65644ab960217e2702e29442022-12-21T19:38:10ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-12-011210.3389/fimmu.2021.763364763364The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the LungMariateresa Coppola0Rachel P-J. Lai1Rachel P-J. Lai2Robert J. Wilkinson3Robert J. Wilkinson4Robert J. Wilkinson5Tom H. M. Ottenhoff6Department Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, Netherlands The Francis Crick Institute, London, United KingdomDepartment of Infectious Diseases, Imperial College London, London, United Kingdom The Francis Crick Institute, London, United KingdomDepartment of Infectious Diseases, Imperial College London, London, United KingdomDepartment of Medicine, Institute of Infectious Disease and Molecular Medicine, Wellcome Centre for Infectious Diseases Research in Africa, Cape Town, South AfricaDepartment Infectious Diseases, Leiden University Medical Center (LUMC), Leiden, NetherlandsMycobacterium tuberculosis (Mtb) genes encoding proteins targeted by vaccines and drugs should be expressed in the lung, the main organ affected by Mtb, for these to be effective. However, the pulmonary expression of most Mtb genes and their proteins remains poorly characterized. The aim of this study is to fill this knowledge gap. We analyzed large scale transcriptomic datasets from specimens of Mtb-infected humans, TB-hypersusceptible (C3H/FeJ) and TB-resistant (C57BL/6J) mice and compared data to in vitro cultured Mtb gene-expression profiles. Results revealed high concordance in the most abundantly in vivo expressed genes between pulmonary Mtb transcriptomes from different datasets and different species. As expected, this contrasted with a lower correlation found with the highest expressed Mtb genes from in vitro datasets. Among the most consistently and highly in vivo expressed genes, 35 have not yet been explored as targets for vaccination or treatment. More than half of these genes are involved in protein synthesis or metabolic pathways. This first lung-oriented multi-study analysis of the in vivo expressed Mtb-transcriptome provides essential data that considerably increase our understanding of pulmonary TB infection biology, and identifies novel molecules for target-based TB-vaccine and drug development.https://www.frontiersin.org/articles/10.3389/fimmu.2021.763364/fullMycobacterium tuberculosis (MTB)transcriptomictuberculosisvaccinetherapyantigen discovery
spellingShingle Mariateresa Coppola
Rachel P-J. Lai
Rachel P-J. Lai
Robert J. Wilkinson
Robert J. Wilkinson
Robert J. Wilkinson
Tom H. M. Ottenhoff
The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
Frontiers in Immunology
Mycobacterium tuberculosis (MTB)
transcriptomic
tuberculosis
vaccine
therapy
antigen discovery
title The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
title_full The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
title_fullStr The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
title_full_unstemmed The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
title_short The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung
title_sort in vivo transcriptomic blueprint of mycobacterium tuberculosis in the lung
topic Mycobacterium tuberculosis (MTB)
transcriptomic
tuberculosis
vaccine
therapy
antigen discovery
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.763364/full
work_keys_str_mv AT mariateresacoppola theinvivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT rachelpjlai theinvivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT rachelpjlai theinvivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT robertjwilkinson theinvivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT robertjwilkinson theinvivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT robertjwilkinson theinvivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT tomhmottenhoff theinvivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT mariateresacoppola invivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT rachelpjlai invivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT rachelpjlai invivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT robertjwilkinson invivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT robertjwilkinson invivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT robertjwilkinson invivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung
AT tomhmottenhoff invivotranscriptomicblueprintofmycobacteriumtuberculosisinthelung